These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 22173163)

  • 41. Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice.
    Ma PF; Gao CC; Yi J; Zhao JL; Liang SQ; Zhao Y; Ye YC; Bai J; Zheng QJ; Dou KF; Han H; Qin HY
    J Hepatol; 2017 Oct; 67(4):770-779. PubMed ID: 28596109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cellular sources of extracellular matrix in hepatic fibrosis.
    Wells RG
    Clin Liver Dis; 2008 Nov; 12(4):759-68, viii. PubMed ID: 18984465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis.
    Forbes SJ; Russo FP; Rey V; Burra P; Rugge M; Wright NA; Alison MR
    Gastroenterology; 2004 Apr; 126(4):955-63. PubMed ID: 15057733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis.
    Motawi TM; Atta HM; Sadik NA; Azzam M
    Cell Biochem Biophys; 2014 Jan; 68(1):111-25. PubMed ID: 23807535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contribution of bone marrow-derived fibrocytes to liver fibrosis.
    Xu J; Cong M; Park TJ; Scholten D; Brenner DA; Kisseleva T
    Hepatobiliary Surg Nutr; 2015 Feb; 4(1):34-47. PubMed ID: 25713803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis.
    Jangra A; Kothari A; Sarma P; Medhi B; Omar BJ; Kaushal K
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transplantation of bone marrow-derived mesenchymal stem cells after regional hepatic irradiation ameliorates thioacetamide-induced liver fibrosis in rats.
    Shao CH; Chen SL; Dong TF; Chai H; Yu Y; Deng L; Wang Y; Cheng F
    J Surg Res; 2014 Jan; 186(1):408-16. PubMed ID: 24071025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment Efficiency of Different Routes of Bone Marrow-Derived Mesenchymal Stem Cell Injection in Rat Liver Fibrosis Model.
    Idriss NK; Sayyed HG; Osama A; Sabry D
    Cell Physiol Biochem; 2018; 48(5):2161-2171. PubMed ID: 30114694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mesenchymal stem cells suppress hepatic fibrosis accompanied by expanded intrahepatic natural killer cells in rat fibrosis model.
    Duman DG; Zibandeh N; Ugurlu MU; Celikel C; Akkoc T; Banzragch M; Genc D; Ozdogan O; Akkoc T
    Mol Biol Rep; 2019 Jun; 46(3):2997-3008. PubMed ID: 30850965
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    Hsu WH; Liao SC; Chyan YJ; Huang KW; Hsu SL; Chen YC; Siu ML; Chang CC; Chung YS; Huang CF
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of human amniotic epithelial cells on pro-fibrogenic resident hepatic cells in a rat model of liver fibrosis.
    Cargnoni A; Farigu S; Cotti Piccinelli E; Bonassi Signoroni P; Romele P; Vanosi G; Toschi I; Cesari V; Barros Sant'Anna L; Magatti M; Silini AR; Parolini O
    J Cell Mol Med; 2018 Feb; 22(2):1202-1213. PubMed ID: 29105277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cellular players in lung fibrosis.
    Lekkerkerker AN; Aarbiou J; van Es T; Janssen RA
    Curr Pharm Des; 2012; 18(27):4093-102. PubMed ID: 22630084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent advancement of molecular mechanisms of liver fibrosis.
    Seki E; Brenner DA
    J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):512-8. PubMed ID: 25869468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transplantation of bone marrow-derived endothelial progenitor cells and hepatocyte stem cells from liver fibrosis rats ameliorates liver fibrosis.
    Lan L; Liu R; Qin LY; Cheng P; Liu BW; Zhang BY; Ding SZ; Li XL
    World J Gastroenterol; 2018 Jan; 24(2):237-247. PubMed ID: 29375209
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The contribution of bone marrow-derived cells to the development of renal interstitial fibrosis.
    Li J; Deane JA; Campanale NV; Bertram JF; Ricardo SD
    Stem Cells; 2007 Mar; 25(3):697-706. PubMed ID: 17170067
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatic myofibroblasts and fibrogenic progression of chronic liver diseases.
    Novo E; Cannito S; Morello E; Paternostro C; Bocca C; Miglietta A; Parola M
    Histol Histopathol; 2015 Sep; 30(9):1011-32. PubMed ID: 25896393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Depletion of Bone Marrow-Derived Fibrocytes Attenuates TAA-Induced Liver Fibrosis in Mice.
    Hempel F; Roderfeld M; Savai R; Sydykov A; Irungbam K; Schermuly R; Voswinckel R; Köhler K; Churin Y; Kiss L; Bier J; Pons-Kühnemann J; Roeb E
    Cells; 2019 Oct; 8(10):. PubMed ID: 31591328
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intracellular sphingosine 1-phosphate contributes to collagen expression of hepatic myofibroblasts in human liver fibrosis independent of its receptors.
    Xiu L; Chang N; Yang L; Liu X; Yang L; Ge J; Li L
    Am J Pathol; 2015 Feb; 185(2):387-98. PubMed ID: 25432063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway.
    Rong X; Liu J; Yao X; Jiang T; Wang Y; Xie F
    Stem Cell Res Ther; 2019 Mar; 10(1):98. PubMed ID: 30885249
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression.
    Caligiuri A; Gentilini A; Pastore M; Gitto S; Marra F
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.